Over the past 500 million years, nearly all evolutionary changes in octopuses and squids occurred in rapid bursts during the emergence of new species ...

Constructive Bio in Cambridge now holds the exclusive licence to ‘tRNA Display’ technology from the MRC Laboratory of ...

Ongoing Phase 2 study enrolling 102 patients in the U.S. and South Korea, with more than 50% of participants identified as Asian ...

A father’s eating habits during his teenage years can have a lasting impact on the nutritional quality of his children’s ...

To address the challenge of controlling protein activation in living animals for gain-of-function studies, researchers from ...

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced its ...

In a comprehensive Genomic Press research article published today, scientists have uncovered a previously unknown ...

Researchers have decoded the mitochondrial DNA of deep-sea sea cucumbers, uncovering unique gene arrangements and genetic ...

Boston, Massachusetts--(Newsfile Corp. - May 15, 2025) - Tevard Biosciences, Inc., a privately held biotechnology company pioneering tRNA-based therapies to cure a broad range of genetic diseases ...

Boston, Massachusetts--(Newsfile Corp. - April 29, 2025) - Tevard Biosciences, Inc., a privately held biotechnology company pioneering tRNA-based therapies to cure a broad range of genetic ...

We have all heard of messenger RNA (mRNA) by now, but what about transfer RNA (tRNA)? Well, there is a growing awareness that this emerging technology is capable of a myriad of biological functions ...

HC Bioscience is shutting down after conducting preclinical models for a transfer RNA (tRNA) asset designed to treat hemophilia A. The Cambridge, Massachusetts-based biotech is closing ...